Suppr超能文献

小肺腺癌的术中诊断及印片细胞学检查的手术操作

Intraoperative Diagnosis and Surgical Procedure with Imprint Cytology for Small Pulmonary Adenocarcinoma.

作者信息

Nakagiri Tomoyuki, Nakayama Tomio, Tokunaga Toshiteru, Takenaka Akemi, Kunoh Hidenori, Ishida Hiroto, Tomita Yasuhiko, Nakatsuka Shin-Ichi, Nakamura Harumi, Okami Jiro, Higashiyama Masahiko

机构信息

Department of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.

Cancer Control and Statistics, Osaka International Cancer Institute Osaka, Japan.

出版信息

J Cancer. 2020 Feb 20;11(10):2724-2729. doi: 10.7150/jca.35026. eCollection 2020.

Abstract

: For patients with multiple small-sized pulmonary cancers, a lobectomy can disrupt future therapeutic options for other lesions. It was recently reported that limited pulmonary resections were not inferior to lobectomy for the management of selected peripheral small-sized pulmonary adenocarcinomas. Patients with adenocarcinoma or minimally invasive adenocarcinoma, as proposed by the International Association for the Study of Cancer classification, have been reported to have 100% survival after 5 years. However, that classification can be applied postoperatively. Since 2005, we have been intentionally performing limited pulmonary resection procedures for small-sized adenocarcinoma cases based on intraoperative imprint cytological diagnosis and our classification (Nakayama-Higashiyama's classification). : A total of 120 consecutive cases were included in this study. Lung tumors were removed intraoperatively by wedge resection, and stump smear cytology was performed, from which the cases were classified into 5 groups based on our classification. When the tumor was classified as Group I or II, the operation was finished. When diagnosed as a more advanced classification, a lobectomy and lymph node dissection were additionally performed. : The 5-year survival rate for Group I and II was 100%, while those for Group III and IV-V were 95.8% and 94.4%, respectively. The 5-year disease-free survival rates for Group I and Group II were 100% and 97.1%, respectively, and for Group III and IV-V they were 100% and 94.1%, respectively. : Use of cytological findings along with Nakayama-Higashiyama's classification for determining operation procedure is effective for treatment of patients with small-sized pulmonary adenocarcinoma.

摘要

对于患有多个小尺寸肺癌的患者,肺叶切除术可能会破坏针对其他病灶的未来治疗选择。最近有报道称,对于某些外周小尺寸肺腺癌的治疗,有限性肺切除术并不逊色于肺叶切除术。据国际癌症研究协会分类法所定义的腺癌或微浸润腺癌患者,据报道其5年后生存率为100%。然而,该分类只能在术后应用。自2005年以来,我们一直基于术中印片细胞学诊断和我们的分类法(中山-东山分类法),针对小尺寸腺癌病例有意施行有限性肺切除手术。

本研究共纳入120例连续病例。术中通过楔形切除术切除肺部肿瘤,并进行残端涂片细胞学检查,根据我们的分类法将病例分为5组。当肿瘤被分类为I组或II组时,手术结束。当诊断为更高级别的分类时,则额外进行肺叶切除术和淋巴结清扫术。

I组和II组的5年生存率为100%,而III组和IV-V组的5年生存率分别为95.8%和94.4%。I组和II组的5年无病生存率分别为100%和97.1%,III组和IV-V组分别为100%和94.1%。

利用细胞学检查结果并结合中山-东山分类法来确定手术方式,对于小尺寸肺腺癌患者的治疗是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfd/7086261/4050d16b9baa/jcav11p2724g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验